COMMUNIQUÉS West-GlobeNewswire

-
Burcon NutraScience Announces Transfer of Listing to Nasdaq Capital Market
06/02/2018 -
Correction from source: Aurora Spine Announces Upsizing of Private Placement
06/02/2018 -
BeiGene Announces Commercial Availability of VIDAZA® (Azacitidine for Injection) in China
06/02/2018 -
Aurora Spine Announces Upsizing of Private Placement
05/02/2018 -
Ari Kellen Acquires Common Shares of Vaxil Bio Ltd.
05/02/2018 -
BeiGene to Present Tislelizumab Data in Urothelial Carcinoma at the 2018 Genitourinary Cancers Symposium
05/02/2018 -
ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017
05/02/2018 -
Results from Phase I Study of CB-839 in Combination with Everolimus or Cabozantinib in Patients with Renal Cell Carcinoma to be Presented at the 2018 American Society of Clinical Oncology Genitourinary Cancer Symposium
05/02/2018 -
Mesa Labs Reports Third Quarter Results
05/02/2018 -
Argos Obtains Option to License PD1 Checkpoint Inhibitors
05/02/2018 -
T2 Biosystems Announces CFO Transition
05/02/2018 -
Actinium Pharmaceuticals to Present at the BIO CEO & Investor Conference
05/02/2018 -
Quotient Limited Updates on Status of MosaiQ Performance and Provides Third Quarter Fiscal 2018 Financial Results
05/02/2018 -
Ossur Hf : Interim Report Q4 2017 and Annual Report 2017
05/02/2018 -
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/02/2018 -
Nuvectra™ Announces Closing of Follow-On Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
05/02/2018 -
Bio-Path Holdings to Present at the BIO CEO & Investor Conference
05/02/2018 -
Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
05/02/2018 -
Emblem Announces Changes to Board of Directors
05/02/2018
Pages